Oarsman Capital, Inc. Bristol Myers Squibb CO Transaction History

Oarsman Capital, Inc.

$413 Million
Q1 2024

A detailed history of Oarsman Capital, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Oarsman Capital, Inc. holds 29,033 shares of BMY stock, worth $1.17 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares

29,033

Previous 28,021 3.61%

Holding current value

$1.17 Million

Previous $1.44 Million 9.53%

% of portfolio

0.38%

Previous 0.38%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$47.98 - $54.4 $48,555 - $55,052	1,012 Added 3.61%	29,033 $1.57 Million
Q4 2023 Feb 16, 2024	BUY	$48.48 - $57.85 $26,857 - $32,048	554 Added 2.02%	28,021 $1.44 Million
Q3 2023 Oct 27, 2023	BUY	$57.89 - $64.73 $268,493 - $300,217	4,638 Added 20.32%	27,467 $1.59 Million
Q2 2023 Aug 10, 2023	SELL	$63.71 - $70.74 $19,941 - $22,141	-313 Reduced 1.35%	22,829 $1.46 Million
Q1 2023 May 11, 2023	BUY	$65.71 - $74.53 $25,429 - $28,843	387 Added 1.7%	23,142 $1.6 Million

Q4 2022 Feb 09, 2023	BUY	$68.48 - $81.09 $35,746 - $42,328	522 Added 2.35%	22,755 $1.64 Million
Q3 2022 Nov 10, 2022	SELL	$0.13 - $76.84 $55 - $32,657	-425 Reduced 1.88%	22,233 $1.58 Million
Q2 2022 Aug 10, 2022	SELL	$72.62 - $79.98 $132,168 - $145,563	-1,820 Reduced 7.44%	22,658 $1.75 Million
Q1 2022 May 11, 2022	BUY	$61.48 - $73.72 $18,751 - $22,484	305 Added 1.26%	24,478 $1.79 Million
Q4 2021 Feb 10, 2022	SELL	$53.63 - $62.52 $8,580 - $10,003	-160 Reduced 0.66%	24,173 $1.51 Million
Q3 2021 Nov 12, 2021	SELL	$59.17 - $69.31 $57,572 - $67,438	-973 Reduced 3.84%	24,333 $1.44 Million
Q2 2021 Aug 12, 2021	SELL	$61.91 - $67.42 $459,372 - $500,256	-7,420 Reduced 22.67%	25,306 $1.69 Million
Q1 2021 May 12, 2021	SELL	$59.34 - $66.74 $336,101 - $378,015	-5,664 Reduced 14.75%	32,726 $2.07 Million
Q4 2020 Feb 11, 2021	BUY	$57.74 - $65.43 $11,259 - $12,758	195 Added 0.51%	38,390 $2.38 Million
Q3 2020 Nov 12, 2020	BUY	$57.43 - $63.64 $106,532 - $118,052	1,855 Added 5.1%	38,195 $2.3 Million
Q2 2020 Aug 13, 2020	BUY	$54.82 - $64.09 $1.15 Million - $1.34 Million	20,950 Added 136.13%	36,340 $2.14 Million
Q1 2020 May 13, 2020	BUY	$46.4 - $67.43 $509,564 - $740,516	10,982 Added 249.14%	15,390 $858,000
Q4 2019 Feb 13, 2020	BUY	$49.21 - $64.19 $216,917 - $282,949	4,408 New	4,408 $283,000
Q4 2018 Feb 13, 2019	SELL	$48.76 - $63.23 $173,098 - $224,466	-3,550 Closed	0 $0
Q3 2018 Nov 07, 2018	SELL	$55.19 - $62.25 $11,038 - $12,450	-200 Reduced 5.33%	3,550 $220,000
Q2 2018 Aug 10, 2018	SELL	$50.53 - $62.98 $9,701 - $12,092	-192 Reduced 4.87%	3,750 $208,000
Q1 2018 May 14, 2018	BUY	$59.92 - $68.98 $11,504 - $13,244	192 Added 5.12%	3,942 $249,000
Q4 2017 Feb 08, 2018	SELL	$59.94 - $65.35 $1,558 - $1,699	-26 Reduced 0.69%	3,750 $230,000
Q3 2017 Nov 13, 2017	BUY	$55.23 - $63.74 $208,548 - $240,682	3,776	3,776 $241,000

Others Institutions Holding BMY

# of Institutions

2,553

Shares Held

1.49B

Call Options Held

25.9M

Put Options Held

20M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $86B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Bristol Myers Squibb CO Transaction History